EZER™ SARS-CoV-2 & Flu & RSV & ADV Antigen Combo Rapid Test Device CE
€0.00
In stock
SKU
P211145
INTENDED USE
The EZER™ SARS-CoV-2 & Flu & RSV & ADV Antigen Combo Rapid Test Device is intended for the simultaneous qualitative detection and differentiation of the nucleocapsid protein antigens from SARS-CoV-2, influenza A, influenza B, Respiratory Syncytial Virus and Adenovirus in direct nasal or nasopharyngeal swab specimens. It’s an in vitro diagnostic test for professional use only.
The detection is based on the antibodies which were developed specifically recognizing and reacting with the nucleoprotein of virus.
Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2, influenza, RSV and ADV can be similar. SARS-CoV-2, influenza A, influenza B, RSV and ADV viral antigens are generally detectable in upper respiratory specimens during the acute phase of infection.
Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status.
SPECIMEN: Nasal Swabbing, Nasopharyngeal Swabbing
TIME TO RESULTS
Allow the samples to react according to the procedure and read the lines that appear in the reading area. Read results at 15 minutes and no more than 30 minutes.
STORAGE CONDITIONS
Test devices must be stored at 2~30°C. DO NOT FREEZE. Devices must be at ambient room temperature at time of testing.
CONTENTS
- Test devices
- Sterilized swabs
- Extraction tubes
- Nozzles
- Tube Stand
- Package insert
The EZER™ SARS-CoV-2 & Flu & RSV & ADV Antigen Combo Rapid Test Device is intended for the simultaneous qualitative detection and differentiation of the nucleocapsid protein antigens from SARS-CoV-2, influenza A, influenza B, Respiratory Syncytial Virus and Adenovirus in direct nasal or nasopharyngeal swab specimens. It’s an in vitro diagnostic test for professional use only.
The detection is based on the antibodies which were developed specifically recognizing and reacting with the nucleoprotein of virus.
Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2, influenza, RSV and ADV can be similar. SARS-CoV-2, influenza A, influenza B, RSV and ADV viral antigens are generally detectable in upper respiratory specimens during the acute phase of infection.
Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status.
SPECIMEN: Nasal Swabbing, Nasopharyngeal Swabbing
TIME TO RESULTS
Allow the samples to react according to the procedure and read the lines that appear in the reading area. Read results at 15 minutes and no more than 30 minutes.
STORAGE CONDITIONS
Test devices must be stored at 2~30°C. DO NOT FREEZE. Devices must be at ambient room temperature at time of testing.
CONTENTS
- Test devices
- Sterilized swabs
- Extraction tubes
- Nozzles
- Tube Stand
- Package insert
| Is Featured? | No |
|---|
Write Your Own Review